Genetic marker could revolutionize neonatal sepsis diagnosis

Fewer than one in five people eligible for lung cancer screening reported being up to date with screening in 2022, though patient navigation added to

Am­gen is mak­ing a ma­jor ad­di­tion to its re­search lead­er­ship, bring­ing for­mer No­var­tis re­search ex­ec­u­tive Jay Brad­ner in­to a top role while shift­ing cur­rent R&D

The hunt for a signal of excess sudden cardiac deaths among young people after COVID-19 vaccination left Oregon health officials empty-handed, they reported. Investigators searched